JPWO2023034740A5 - - Google Patents
Info
- Publication number
- JPWO2023034740A5 JPWO2023034740A5 JP2024512984A JP2024512984A JPWO2023034740A5 JP WO2023034740 A5 JPWO2023034740 A5 JP WO2023034740A5 JP 2024512984 A JP2024512984 A JP 2024512984A JP 2024512984 A JP2024512984 A JP 2024512984A JP WO2023034740 A5 JPWO2023034740 A5 JP WO2023034740A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- polypeptide
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163238429P | 2021-08-30 | 2021-08-30 | |
| US63/238,429 | 2021-08-30 | ||
| PCT/US2022/075581 WO2023034740A1 (en) | 2021-08-30 | 2022-08-29 | Nkp46-binding polypeptides and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024534838A JP2024534838A (ja) | 2024-09-26 |
| JP2024534838A5 JP2024534838A5 (https=) | 2025-08-12 |
| JPWO2023034740A5 true JPWO2023034740A5 (https=) | 2025-08-12 |
Family
ID=84047735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512984A Pending JP2024534838A (ja) | 2021-08-30 | 2022-08-29 | ＮＫｐ４６結合ポリペプチド及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250136681A1 (https=) |
| EP (1) | EP4395895A1 (https=) |
| JP (1) | JP2024534838A (https=) |
| CN (1) | CN117940454A (https=) |
| CA (1) | CA3228815A1 (https=) |
| TW (1) | TW202319397A (https=) |
| WO (1) | WO2023034740A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024206329A1 (en) | 2023-03-27 | 2024-10-03 | Modernatx, Inc. | Nucleic acid molecules encoding bi-specific secreted engagers and uses thereof |
| CN120025440A (zh) * | 2023-11-21 | 2025-05-23 | 南京融捷康生物科技有限公司 | 一种抗Nkp46的单域抗体及其用途 |
| WO2025137555A1 (en) * | 2023-12-20 | 2025-06-26 | Omniab, Inc. | Polypeptides that bind to nkp46 |
| WO2025168114A1 (en) * | 2024-02-09 | 2025-08-14 | Shanghai Epimab Biotherapeutics Co., Ltd. | Multifunctional nk cell engager |
| CN120574323A (zh) * | 2024-02-29 | 2025-09-02 | 安升（上海）医药科技有限公司 | 一种抗NKp46的单域抗体及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016207278A1 (en) * | 2015-06-23 | 2016-12-29 | Innate Pharma | Multispecific nk engager proteins |
| US20210024631A1 (en) * | 2018-03-28 | 2021-01-28 | Orionis Biosciences, Inc. | Bi-functional proteins and construction thereof |
| KR20210113265A (ko) * | 2019-01-07 | 2021-09-15 | 인히브릭스, 인크. | 변형된 il-2 폴리펩타이드를 포함하는 폴리펩타이드 및 이의 용도 |
-
2022
- 2022-08-29 EP EP22798405.1A patent/EP4395895A1/en active Pending
- 2022-08-29 WO PCT/US2022/075581 patent/WO2023034740A1/en not_active Ceased
- 2022-08-29 TW TW111132424A patent/TW202319397A/zh unknown
- 2022-08-29 CA CA3228815A patent/CA3228815A1/en active Pending
- 2022-08-29 US US18/685,665 patent/US20250136681A1/en active Pending
- 2022-08-29 CN CN202280058826.6A patent/CN117940454A/zh active Pending
- 2022-08-29 JP JP2024512984A patent/JP2024534838A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025102819A5 (https=) | ||
| JP2021520812A5 (https=) | ||
| JP2020536549A5 (https=) | ||
| JP2020516287A5 (https=) | ||
| JPWO2021155071A5 (https=) | ||
| JPWO2019200022A5 (https=) | ||
| JP2021534783A5 (https=) | ||
| JP2022116230A5 (https=) | ||
| JP2019513347A5 (https=) | ||
| JP2018527008A5 (https=) | ||
| JP2021525524A5 (https=) | ||
| JP2020508334A5 (https=) | ||
| JP2020536543A5 (https=) | ||
| IL319102A (en) | Guidance and navigation control proteins and method for producing and using them | |
| JPWO2020135201A5 (https=) | ||
| CN115698088A (zh) | 免疫细胞衔接器多特异性结合蛋白及其制备和应用 | |
| JPWO2020146221A5 (https=) | ||
| CN117940454A (zh) | NKp46结合多肽及其用途 | |
| JP2025504363A (ja) | γδＴ細胞結合ポリペプチド及びその使用 | |
| Li et al. | Nanobodies and their derivatives: pioneering the future of cancer immunotherapy | |
| JPWO2023034740A5 (https=) | ||
| JPWO2023004304A5 (https=) | ||
| JPWO2023133394A5 (https=) | ||
| WO2023019179A1 (en) | Process for producing armed immune cells | |
| CN115433282A (zh) | 抗cd3抗体变异体、融合蛋白及应用 |